HC Wainwright & Co. maintains Collegium Pharmaceutical [COLL] at Buy rating with a $33 price target
HC Wainwright & Co. maintained its Collegium Pharmaceutical [COLL] rating to the equivalent of Buy but changed the price target to $33.0 from $29, in a research note dated 2021-01-11. That figure represents around a 52.14% premium from where the company’s shares closed on Friday. Some new analysts also started their coverage, with Guggenheim’s analysts […]
